Pharmafile Logo

Political Intelligence

Political Intelligence is an independent European public affairs consultancy, with offices in London, Brussels, Madrid, Edinburgh and Rome.  We provide our clients with practical public affairs advice that helps them to achieve their business objectives. Our professional and dedicated consultancy service includes political monitoring & intelligence, stakeholder engagement programmes, political and policy research, strategic advice, event management and public affairs training. With our interdisciplinary team we deliver a comprehensive public affairs service throughout the EU.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Company Details

69 Wilson Street, London, EC2A 2BB, United Kingdom
+44 (0)20 3397 3300

 Latest Content from PMHub 

OPEN Health Presents First Collection of Research Backed by Scientific Buyout Fund to Foster Research and Development

Press Releases | November 11, 2024 | OPEN Health

OPEN Health is excited to announce the upcoming presentation of a collection of research supported by its Scientific Buyout Program. This initiative empowers our team members to dedicate time toward...

Medscape Publication is Awarded Poster of Distinction at AASLD

Press Releases | November 7, 2024 | Medscape Education

Medscape Education is committed to disseminating the outcomes of the education programs through peer-reviewed publications and posters at leading medical conferences around the world. To this end, Medscape publishes more...

Advancing Education at AASLD 2024

Press Releases | November 7, 2024 | Medscape Education

Get ready for an exciting experience at AASLD 2024! The Medscape team is thrilled to be in San Diego from November 15-19 for this year’s AASLD conference, where we will...

Infographic: Advantages & Disadvantages of Different Meeting Formats

Press Releases | November 7, 2024 | Impetus Digital

Discover the unique pros and cons of in-person, hybrid, synchronous virtual, and asynchronous virtual meetings with our detailed infographic. Perfect for anyone planning efficient and engaging meetings, especially in pharmaceutical...

FINDING OPPORTUNITIES IN YOUR DIGITAL MARKETING STRATEGY

White Papers and Resources | November 6, 2024 | IGNIFI

Digital marketing serves as a critical component within a successful omnichannel strategy, guaranteeing seamless experiences for healthcare professionals and patients across various online platforms. It plays a pivotal role in...

Why is storytelling changing the way we do health comms?

White Papers and Resources | November 5, 2024 | Mednet

Principal Medical Writer, Dr Alexandra Loveday explores the importance of storytelling in health communications.

EatMoreFruit announces launch of European PR Network

Press Releases | November 4, 2024 | EatMoreFruit

EatMoreFruit, a UK top 10 independent healthcare communication agency, today announced the launch of its European Network to support new and existing clients across the diagnostics, med tech, life sciences,...

What if you could shape your next campaign messaging with the media before launch?

Press Releases | November 4, 2024 | EatMoreFruit

Sometimes you just can’t see the wood from the trees. Teams gets so focussed on the technology or treatment you’re selling that the inevitable outcome is a feature-peddling monologue where...

Is your influenza clinical trial prepared for the upcoming flu season? Part 3

This blog will discuss some important aspects to consider to maximise patient retention on your flu clinical trials. For more information on patient recruitment considerations, check out our previous blogs...

Is your influenza clinical trial prepared for the upcoming flu season? Part 2

Around 86% of clinical trials do not meet patient recruitment goals, ultimately failing to improve patient outcomes and resulting in financial losses for sponsors and research sites (Rangu and Maxwell,...